A new partnership between Victoria and South Africa will fast track international collaboration on the development and manufacture of next generation mRNA vaccines and medicines.
A partnership signed today by representatives of mRNA Victoria, Afrigen Biologics and the South African Medical Research Council will develop mRNA vaccine collaboration between the two jurisdictions including, a South-African based World Health Organisation mRNA Technology Transfer Hub in South Africa.
The initiative is aimed to improve low-cost mRNA vaccine production capacity in low- and middle-income countries worldwide and train international workforces in mRNA vaccine advanced manufacturing, an official press release said.
The Memorandum of Understanding will focus on sharing knowledge across three key areas – best-practice mRNA advanced manufacturing, mRNA workforce training and development and research collaboration.
The Afrigen Biologics and South African Medical Research Council delegation will visit Victorian research institutes – including the Peter Doherty Institute for Infection & Immunity, Burnet Institute, and Monash Biomedicine Discovery Institute at Monash University’s Clayton campus – to discuss potential collaborations.
The partnership signed with Afrigen Biologics and South African Medical Research Council follows previous partnership agreements signed by mRNA Victoria with the United Arab Emirates and South Korea, along with global mRNA industry leaders including Moderna and BioNTech to establish operations in Melbourne.
With global medical research over the next decade expected to be dominated by mRNA research, Melbourne has become the leading site for medical research in the Indo-Pacific, home to global innovative biotechnology companies and world-renowned medical research institutions, the release said.
The Labor Government has invested $1.3 billion in medical research since 2014, and has helped create more than 100,000 direct and indirect full-time jobs in the state’s biotech sector.
Support independent community journalism. Support The Indian Sun.
Follow The Indian Sun on Twitter | Instagram | Facebook
A new partnership between #Victoria & South Africa will fast track international collaboration on the development & manufacture of next generation #mRNA #vaccines💉 & #medicines.💊 #TheIndianSunhttps://t.co/R3ezwKKa3z
— The Indian Sun (@The_Indian_Sun) April 27, 2023
Donate To The Indian Sun
Dear Reader,The Indian Sun is an independent organisation committed to community journalism. We have, through the years, been able to reach a wide audience especially with the growth of social media, where we also have a strong presence. With platforms such as YouTube videos, we have been able to engage in different forms of storytelling. However, the past few years, like many media organisations around the world, it has not been an easy path. We have a greater challenge. We believe community journalism is very important for a multicultural country like Australia. We’re not able to do everything, but we aim for some of the most interesting stories and journalism of quality. We call upon readers like you to support us and make any contribution. Do make a DONATION NOW so we can continue with the volume and quality journalism that we are able to practice.
Thank you for your support.
Best wishes,
Team The Indian Sun
